TABLE 5.
Meta-analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|
Lo10 | Bhandari2 | Khan (2005)9 | Khan (2010)8 | Zhao21 | Jiang6 | Wilkins20 | Soroceanu17 | van der Eng18 | |
Statistical heterogeneity analysis | − | + | + | + | + | + | − | + | + |
Subgroup or sensitivity analysis | |||||||||
Rerupture rate | |||||||||
Open operative vs nonoperative | − | − | + | + | − | − | − | − | − |
Open vs percutaneous | − | − | + | + | − | − | − | − | − |
Cast immobilization alone vs cast immobilization then functional bracing in operative treatment | − | − | + | − | − | − | − | − | − |
Cast immobilization vs functional bracing in nonoperative treatment | − | − | + | − | − | − | − | − | − |
Augmented repair vs simple repair in operative treatment | − | − | − | + | − | − | − | − | − |
Operative vs nonoperative | |||||||||
Patients with weightbearing initiated ≤4 wk after treatment | − | − | − | − | − | − | − | − | + |
Patients with weightbearing initiated >4 wk after treatment | − | − | − | − | − | − | − | − | + |
Patients with early ROM functional rehabilitation | − | − | − | − | − | − | − | + | − |
Patients with prolonged immobilization rehabilitation protocol | − | − | − | − | − | − | − | + | − |
Patients in only high-Jadad-score (≥4) RCTs | − | − | − | − | − | + | − | − | − |
Adhesion rate | |||||||||
Open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Open vs percutaneous | − | − | − | + | − | − | − | − | − |
Operative vs nonoperative in patients in only high-Jadad-score (≥4) RCTs | − | − | − | − | − | + | − | − | − |
DVT rate | |||||||||
Open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Open vs percutaneous | − | − | − | + | − | − | − | − | − |
Skin-related complications (other than adhesions) rate: open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Disturbing scar/wound puckering rate: open vs percutaneous | − | − | − | + | − | − | − | − | − |
Sural nerve injury/sensibility disturbance rate: open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Sensibility disturbance rate: operative vs nonoperative in patients in only high-Jadad- score (≥4) RCTs | − | − | − | − | − | + | − | − | − |
Complications excluding rerupture rate | |||||||||
Operative vs nonoperative | − | − | + | + | − | − | − | − | − |
Open vs percutaneous | − | − | + | − | − | − | − | − | − |
Cast immobilization alone vs cast immobilization then functional bracing in operative treatment | − | − | + | − | − | − | − | − | − |
All complications rate: operative vs nonoperative in patients in only high-Jadad-score (≥4) RCTs | − | − | − | − | − | + | − | − | − |
Major complications rate | |||||||||
Operative vs nonoperative in patients with weightbearing initiated ≤4 wk after treatment | − | − | − | − | − | − | − | − | + |
Operative vs nonoperative in patients with weightbearing initiated >4 wk after treatment | − | − | − | − | − | − | − | − | + |
Minor complication rate | |||||||||
Operative vs nonoperative in patients with weightbearing initiated ≤4 wk after treatment | − | − | − | − | − | − | − | − | + |
Operative vs nonoperative in patients with weightbearing initiated >4 wk after treatment | − | − | − | − | − | − | − | − | + |
Total infection rate | |||||||||
Open operative vs nonoperative | − | − | + | + | − | − | − | − | − |
Open vs percutaneous | − | − | + | + | − | − | − | − | − |
Deep infection rate | |||||||||
Open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Open vs percutaneous | − | − | − | + | − | − | − | − | − |
Augmented repair vs simple repair in operative treatment | − | − | − | + | − | − | − | − | − |
Operative vs nonoperative in patients in only high-Jadad-score (≥4) RCTs | − | − | − | − | − | + | − | − | − |
Superficial infection rate | |||||||||
Open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Open vs percutaneous | − | − | − | + | − | − | − | − | − |
Return to former level of sporting: open operative vs nonoperative | − | − | − | + | − | − | − | − | − |
Sporting activity postrupture: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Time off work: open vs percutaneous | − | − | − | 0 | − | − | − | − | − |
Satisfaction: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Range of motion: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Calf circumference: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Power of plantar flexion: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Tendon width: open operative vs nonoperative | − | − | − | 0 | − | − | − | − | − |
Duration of operation: open vs percutaneous | − | − | − | 0 | − | − | − | − | − |
a“+” indicates formal sensitivity or subgroup analysis was performed, “−” indicates formal sensitivity or subgroup analysis was not performed, and “0” indicates descriptive data were provided or discussed, but no analysis was performed. DVT, deep vein thrombosis; RCT, randomized controlled trial; ROM, range of motion.